Sun Pharma buys Disperzyme, Phlogam brands from Aksigen Hospital Care1 min read . Updated: 30 Jan 2023, 04:17 PM IST
- All three brands are approved by the DCGI for post-operative inflammation in patients undergoing minor surgery and dental procedures
Mumbai: Indian drug major Sun Pharmaceutical Industries on Monday said it has bought anti-inflammatory brands Disperzyme, Disperzyme-CD, and Phlogam from Mumbai-based Aksigen Hospital Care for an undisclosed amount.
Select your Category